Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants
Clinical trial NCT03870763 · TERMINATED
Trial details
- NCT number
- NCT03870763
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2022-07-21
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.